Skip to main content
SpringerLink
Log in

Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To evaluate the risk factors affecting early diffuse recurrence within 1 year of percutaneous ultrasound-guided radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC).

Methods

Out of 146 patients who received transcatheter arterial chemoembolisation (TACE) for treatment of recurrent HCC after percutaneous ultrasound-guided RFA, we selected 23 patients with early diffuse recurrence. Early diffuse recurrence was defined as three or more new recurrent HCCs within 1 year of initial RFA. As a control group, we selected 23 patients, matched exactly for age and sex, in which there was no local tumour progression or new recurrence after RFA. To analyse the risk factors, we examined patient factors and tumour factors.

Results

Recurrent tumours occurred from 30 to 365 days after RFA (median time, 203 days). Univariate analysis indicated that larger tumour size and poorly defined margin were significant risk factors (P < 0.05). Multivariate analysis indicated that poorly defined margin was a significant risk factor (P < 0.05).

Conclusion

Larger tumour size and poorly defined margin may be risk factors for early diffuse recurrence of HCC within 1 year of RFA. Tumours with such risk factors should be treated with a combination of TACE to minimise the potential for therapeutic failure.

Key Points

• Ultrasound-guided radiofrequency ablation (RFA) is widely used for hepatocellular carcinoma (HCC).

• Early diffuse recurrence after RFA is an important prognostic factor

• The risk factors for recurrence are larger tumour size and poorly defined margins

• Tumours with such risk factors should be treated with transarterial chemoembolisation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271–285

    Article  PubMed  CAS  Google Scholar 

  2. (1980) Primary liver cancers in Japan. Cancer 45:2663–2669

  3. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J (1995) Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 221:291–298

    Article  PubMed  CAS  Google Scholar 

  4. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM (2005) Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 31:331–347

    Article  PubMed  CAS  Google Scholar 

  5. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, Silverman DE, Buscarini L (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167:759–768

    PubMed  CAS  Google Scholar 

  6. Ono K, Kokubu S, Hidaka H, Watanabe M, Nakazawa T, Saigenji K (2005) Risk factors of delay in restoration of hepatic reserve capacity and local recurrence after radiofrequency ablation therapy for hepatocellular carcinoma (HCC). Hepatol Res 31:172–177

    Article  PubMed  CAS  Google Scholar 

  7. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130

    Article  PubMed  Google Scholar 

  8. Cho YK, Kim JK, Kim MY, Rhim H, Han JK (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–459

    Article  PubMed  Google Scholar 

  9. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328

    Article  PubMed  Google Scholar 

  10. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J (2004) Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 85:36–41

    Article  PubMed  Google Scholar 

  11. Park UJ, Kim YH, Kang KJ, Lim TJ (2008) Risk factors for early recurrence after surgical resection for hepatocellular carcinoma. Korean J Hepatol 14:371–380

    Article  PubMed  Google Scholar 

  12. Zou WL, Zang YJ, Chen XG, Shen ZY (2008) Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Hepatobiliary Pancreat Dis Int 7:145–151

    PubMed  Google Scholar 

  13. Kim BW, Kim YB, Wang HJ, Kim MW (2006) Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 12:99–104

    PubMed  Google Scholar 

  14. Kotoh K, Enjoji M, Arimura E, Morizono S, Kohjima M, Sakai H, Nakamuta M (2005) Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma. World J Gastroenterol 11:6828–6832

    PubMed  Google Scholar 

  15. Seki T, Tamai T, Ikeda K, Imamura M, Nishimura A, Yamashiki N, Nakagawa T, Inoue K (2001) Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol 13:291–294

    Article  PubMed  CAS  Google Scholar 

  16. Portolani N, Tiberio GA, Ronconi M, Coniglio A, Ghidoni S, Gaverini G, Giulini SM (2003) Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepatogastroenterology 50:2179–2184

    PubMed  Google Scholar 

  17. Ruzzenente A, Manzoni GD, Molfetta M, Pachera S, Genco B, Donataccio M, Guglielmi A (2004) Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol 10:1137–1140

    PubMed  Google Scholar 

  18. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  19. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K (1991) Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 14:802–805

    Article  PubMed  CAS  Google Scholar 

  20. Lim JH, Jang HJ, Kim EY, Park CK, Joh JW, Kim YI (2000) Early recurring hepatocellular carcinoma after partial hepatic resection: preoperative CT findings. Korean J Radiol 1:38–42

    Article  PubMed  CAS  Google Scholar 

  21. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141:330–339

    Article  PubMed  Google Scholar 

  22. Lai EC, You KT, Ng IO, Shek TW (1993) The pathological basis of resection margin for hepatocellular carcinoma. World J Surg 17:786–790, discussion 791

    Article  PubMed  CAS  Google Scholar 

  23. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202:275–283

    Article  PubMed  Google Scholar 

  24. Kotoh K, Nakamuta M, Morizono S, Kohjima M, Arimura E, Fukushima M, Enjoji M, Sakai H, Nawata H (2005) A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time. Liver Int 25:542–547

    Article  PubMed  Google Scholar 

  25. Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M (2009) Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int 3:509-515

    Google Scholar 

  26. Kobayashi M, Ikeda K, Someya T, Akuta N, Suzuki F, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Kumada H (2002) Stepwise hook extension technique for radiofrequency ablation therapy of hepatocellular carcinoma. Oncology 63:139–144

    Article  PubMed  Google Scholar 

  27. Yu HC, Cheng JS, Lai KH, Lin CP, Lo GH, Lin CK, Hsu PI, Chan HH, Lo CC, Tsai WL, Chen WC (2005) Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 11:1439–1444

    PubMed  Google Scholar 

  28. Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, Kim PN (2011) Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol 18:1624–1629

    Article  PubMed  Google Scholar 

  29. Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, Shiraki K, Yamada T, Takeda K (2009) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 20:217–224

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunwan University, School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul, 135-710, Korea

    Hee Young Lee, Hyunchul Rhim, Min Woo Lee, Young-sun Kim, Dongil Choi, Min Jung Park, Young Kon Kim, Seong Hyun Kim & Hyo Keun Lim

Authors
  1. Hee Young Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyunchul Rhim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Woo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Young-sun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dongil Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Min Jung Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Young Kon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Seong Hyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hyo Keun Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyunchul Rhim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, H.Y., Rhim, H., Lee, M.W. et al. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol 23, 190–197 (2013). https://doi.org/10.1007/s00330-012-2561-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2561-8

Keywords

Search

Navigation